Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02760069 · ClinicalTrials.gov registry record · Phase 4
Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department
A Phase 4 study of Nausea, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 122
- Enrollment target
- 1
- Study location
NCT02760069: Completed Phase 4 study of Nausea, sponsored by Brooke Army Medical Center.
NCT02760069 is a Phase 4 study of Nausea that has completed, run by Brooke Army Medical Center. The registered enrollment target is 122 participants, below the 237-participant average among 17 other Nausea trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02760069, a Phase 4 study of Nausea, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 122 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the efficacy of isopropyl alcohol and conventional anti-emetics with three study arms: (1) inhaled isopropyl alcohol plus oral ondansetron; (2) inhaled isopropyl alcohol plus oral placebo; (3) inhaled placebo plus oral ondansetron.
Primary Outcome
Full Scale Name: Nausea 100-mm visual analogue scale. Scale Construct: Measures nausea as reported by the patient Scale Range: Minimum is 0 (no nausea) to 100 (worst nausea imaginable). These values quantify, on an interval scale anchored at 0, the patient's subjective sensation of nausea. Higher values represent worse outcomes (e.g., more nausea). Patient makes a single vertical mark on a 100 mm horizontal line with 0 at the left and 100 on the right to depict their nausea.
Conditions Studied
Interventions
- DRUG Inhaled isopropyl alcohol
- DRUG Oral ondansetron
- DRUG Inhaled normal saline
- DRUG Oral placebo
Study Locations (1)
Texas
- San Antonio Military Medical Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-11 |
| Phase | Phase 4 |
What the finished NCT02760069 record still lists
NCT02760069 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 237-participant average among 17 other Nausea trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Nausea appearing as the primary indexed condition, and to 4 interventions - of which Inhaled isopropyl alcohol is the first listed.
NCT02760069 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02760069 about?
NCT02760069 is a clinical study titled "Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department". This study will compare the efficacy of isopropyl alcohol and conventional anti-emetics with three study arms: (1) inhaled isopropyl alcohol plus oral ondansetron; (2) inhaled isopropyl alcohol plus oral placebo; (3) inhaled placebo plus oral ondansetron.
What is the current status of trial NCT02760069?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 122 participants. The study started on 2016-01. Estimated completion is 2017-11.
What conditions does trial NCT02760069 study?
This clinical trial studies the following conditions: Nausea.
What interventions are being tested in trial NCT02760069?
The interventions under investigation include: Inhaled isopropyl alcohol (DRUG), Oral ondansetron (DRUG), Inhaled normal saline (DRUG), Oral placebo (DRUG).
Who is sponsoring clinical trial NCT02760069?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02760069 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nausea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02760069's enrollment target sits among peer trials
122 8th of 17 higher than 9 of 17 other Nausea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nausea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting
COMPLETED · Phase 4
-
The Montefiore Metoclopramide Study
COMPLETED · Phase 4
-
Inhaled Isopropyl Alcohol for Treatment of Nausea
RECRUITING · Phase 2
-
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
RECRUITING · NA
-
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
RECRUITING · Phase 2
-
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia